Enlivex Ltd (ENLV) Unusual Options Activity Today

Checking ENLV unusual options activity helps you spot when traders are making outsized bets on Enlivex Ltd before the broader market catches on. Enlivex Ltd's unusual options activity flags contracts trading at multiples of their average daily volume, often signaling that informed money is positioning ahead of a catalyst. Use our scanner to monitor ENLV unusual options activity today and surface the prints that deserve a second look.

Unusual options flow typically refers to trades where volume vastly exceeds open interest at a given strike, or where total contract volume on a name spikes well above its norm. Watching ENLV unusual options flow today can reveal large block trades, sweeps across exchanges, and aggressive directional bets. Tracking ENLV unusual options volume across calls and puts helps you separate hedging activity from genuinely speculative positioning, and ENLV unusual options flow data becomes especially valuable around earnings, product launches, and macro events.

Enlivex Therapeutics Ltd. operates as a clinical-stage macrophage reprogramming immunotherapy company. It is developing Allocetra, a cell-based therapy to treat organ dysfunction and failure associated with sepsis that is in phase II clinical trial, as well as in preclinical trial to treat solid tumors. Enlivex Therapeutics Ltd. was founded in 2005 and is headquartered in Nes Ziona, Israel.

Catalysts rarely arrive without a footprint, and ENLV unusual options activity is often where that footprint shows up first. Our scanner tracks Enlivex Ltd's unusual options flow in real time, ranks prints by volume-to-open-interest, premium spent, and aggressor side, and separates real conviction from noise. Whether you're looking at ENLV unusual options volume on the call side or chasing put sweeps, Enlivex Ltd's unusual options flow today is one click away, so put it on your radar before the headlines hit.